CompletedNot Applicable

Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

India54 participantsStarted 2022-07-01

Plain-language summary

Cavernous sinus syndrome (CSS) can be caused by a wide range of inflammatory, malignant, benign, vascular and miscellaneous disorders. Even after modern advances, reaching the final etiological diagnosis remains a challenge in CSS. This study is planned to determine the role and incremental value of 18F-FDG PET/CT in characterising different cavernous sinus pathologies based on their metabolic activity and detecting extracranial involvement.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with age greater than or equal to 18 years,
✓. with newly diagnosed CSS,
✓. lesion seen on MRI in the CS, and
✓. willing to give written informed consent.

Exclusion criteria

✕. Pregnant and lactating patients
✕. Patients already being treated (including steroids)

What they're measuring

SUVmax of the cavernous sinus lesions on FDG PET/CT

Timeframe: From enrollment to the establishment of final diagnosis upto a period of three months

Number of patients with extracranial sites of involvement on FDG PET/CT

Timeframe: From enrollment to the establishment of final diagnosis upto 3 months

Trial details

NCT IDNCT06721130

SponsorPost Graduate Institute of Medical Education and Research, Chandigarh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Cavernous Sinus Syndrome trials